Duodenal fistula rarely occurs in patients with Crohn’s disease (CD), most arising from recurrent disease at the ileocolic anastomosis [1]. The treatment for duodenal fistula includes medical or surgical management, and surgery is often required [1‐3]. We report the case of a 32-year-old male diagnosed with CD 8 years prior. He had undergone four operations owing to external and internal fistulas. However, the duodenal fistula recurred after operations, and was also unsuccessfully treated with medical therapy and a patch blocking (Fig. 1). Reoperation was not feasible in the short term, so the conservative treatment is challenging. We made a modified percutaneous endoscopic gastrojejunostomy (PEG-J) that was placed though the abdominal fistula to achieve decompression and enteral nutrition (Figs. 2, 3). The patient had no complications of duodenal fistula. One year later, the duodenal fistula was successfully treated by surgery (Fig. 4). We suggest that modified PEG-J is an option to treat upper gastrointestinal fistula that is inoperable.
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.